 |
|
|
| |
Pharmacokinetics and Safety of MK-8527 in
Adults With Moderate or Severe Renal Impairment
|
| |
| |
EACS 2025 Oct 15-18 Paris
Russ P. Carstens1; Yash Kapoor1; Arinjita Bhattacharyya1; Bhavna Kantesaria1; Graigory C. Garrett1; Gillian Gillespie1; Ryan Vargo1; S. Aubrey Stoch1,; Helen Manthos2; Abe Lambert2; Jesse C. Nussbaum1,*
1Merck & Co., Inc., Rahway, NJ, USA; 2Celerion, Lincoln, NE, USA
*Presenting author
An employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA,
at the time the study was conducted
|
| |
|
|
|
|
|
